Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Deep learning–based molecular morphometrics for kidney biopsies
Marina Zimmermann, … , Stefan Bonn, Victor G. Puelles
Marina Zimmermann, … , Stefan Bonn, Victor G. Puelles
Published March 11, 2021
Citation Information: JCI Insight. 2021;6(7):e144779. https://doi.org/10.1172/jci.insight.144779.
View: Text | PDF
Resource and Technical Advance Nephrology

Deep learning–based molecular morphometrics for kidney biopsies

  • Text
  • PDF
Abstract

Morphologic examination of tissue biopsies is essential for histopathological diagnosis. However, accurate and scalable cellular quantification in human samples remains challenging. Here, we present a deep learning–based approach for antigen-specific cellular morphometrics in human kidney biopsies, which combines indirect immunofluorescence imaging with U-Net–based architectures for image-to-image translation and dual segmentation tasks, achieving human-level accuracy. In the kidney, podocyte loss represents a hallmark of glomerular injury and can be estimated in diagnostic biopsies. Thus, we profiled over 27,000 podocytes from 110 human samples, including patients with antineutrophil cytoplasmic antibody–associated glomerulonephritis (ANCA-GN), an immune-mediated disease with aggressive glomerular damage and irreversible loss of kidney function. We identified previously unknown morphometric signatures of podocyte depletion in patients with ANCA-GN, which allowed patient classification and, in combination with routine clinical tools, showed potential for risk stratification. Our approach enables robust and scalable molecular morphometric analysis of human tissues, yielding deeper biological insights into the human kidney pathophysiology.

Authors

Marina Zimmermann, Martin Klaus, Milagros N. Wong, Ann-Katrin Thebille, Lukas Gernhold, Christoph Kuppe, Maurice Halder, Jennifer Kranz, Nicola Wanner, Fabian Braun, Sonia Wulf, Thorsten Wiech, Ulf Panzer, Christian F. Krebs, Elion Hoxha, Rafael Kramann, Tobias B. Huber, Stefan Bonn, Victor G. Puelles

×

Figure 3

Application of segmentation U-Net to human kidney biopsies.

Options: View larger image (or click on image) Download as PowerPoint
Application of segmentation U-Net to human kidney biopsies.
(A) Visual r...
(A) Visual representation of the segmentation process, from original images, to segmentation outputs for glomeruli and podocytes, and their respective correlation with manually segmented ground truths, highlighting true positives, false positives, and false negatives. (B) Receiver operating characteristic (ROC) and precision-recall curves in samples from controls and ANCA-GN patients; arrowheads show selected thresholds for both conditions (n = 20 images for Controls 1, n = 24 images for Controls 2, and n = 21 images for ANCA-GN patients). (C) Dice scores at pixel and object levels for glomeruli and podocytes, showing comparable segmentation performance in health and disease (n = 44 images for controls and n = 21 images for ANCA-GN patients; Mann-Whitney U tests were performed). In dot plots, each blue dot represents 1 image, and red error bars represent medians and IQRs. ANCA-GN, antineutrophil cytoplasmic antibody–associated glomerulonephritis; DACH1, Dachshund Family Transcription Factor 1; WT1, Wilms’ Tumor 1; TPR, true positive rate; FPR, false positive rate; TP, true positives; FP, false positives; FN, false negatives. ***P < 0.001. Scale bars: 100 μm.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts